SPECT/CT imaging of lung cancers with 99mTc‐HYNIC‐αLAG‐3 and 99mTc‐HYNIC‐αPD‐L1 probes represents an effective method for noninvasively visualizing LAG‐3 and PD‐L1, and immunotherapy resistance monitoring. This evidence concerns the gene CD274 and lung cancer.